Grufity logo
Grufity logo
AEMD

AEMD - Aethlon Medical Inc Stock Price, Fair Value and News

$1.93-0.07 (-3.50%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

83/100

AEMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

83/100

AEMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

AEMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AEMD Price Action

Last 7 days

-2.0%

Last 30 days

-5.2%

Last 90 days

-10.4%

Trailing 12 Months

-88.7%

AEMD RSI Chart

AEMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AEMD Valuation

Market Cap

3.0M

Price/Earnings (Trailing)

-0.42

Price/Sales (Trailing)

7.6

Price/Free Cashflow

-0.43

AEMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

AEMD Fundamentals

AEMD Revenue

Revenue (TTM)

417.3K

Rev. Growth (Yr)

-11.86%

Rev. Growth (Qtr)

-17.67%

AEMD Earnings

Earnings (TTM)

-7.2M

Earnings Growth (Yr)

69.88%

Earnings Growth (Qtr)

6.64%

AEMD Profitability

Return on Equity

-146.36%

Return on Assets

-112.92%

Free Cashflow Yield

-231.02%

AEMD Investor Care

Shares Dilution (1Y)

681.03%

Diluted EPS (TTM)

-12.45

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2025----
2024-417.3K--
2023574.2K535.0K495.8K456.5K
2022294.2K---
20211.3M997.8K923.0K315.3K
2020650.2K--1.2M
2019229.6K110.0K110.0K523.5K
2018149.6K299.3K299.3K224.4K
2017392.1K--462.3K
2016886.6K762.9K639.3K515.7K
2015762.4K903.6K612.9K880.5K
20141.6M1.4M1.2M977.8K
20131.2M1.2M1.5M1.3M
20121.4M1.7M2.0M1.2M
2011----
2010----
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Aethlon Medical Inc

AEMD
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
 CEO
 WEBSITEaethlonmedical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES15

Aethlon Medical Inc Frequently Asked Questions

AEMD is the stock ticker symbol of Aethlon Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of Aethlon Medical Inc is 3.14 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, AEMD's PE ratio (Price to Earnings) is -0.44 and Price to Sales (PS) ratio is 7.6. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AEMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Aethlon Medical Inc has provided -0.647 (multiply by 100 for percentage) rate of return.